Sign in
Industry guide

Orthodontic Practice
Financing & Valuation

Orthodontics sits at the premium end of dental specialties: high-margin, predominantly cash-pay, with predictable subscription-like revenue from multi-year treatment contracts. DSOs and PE-backed orthodontic platforms have transformed the market in the past five years.

4-9xEBITDA multiple
75%Cash / commercial pay
$800K-$8MTransaction range
90-120dAvg. close

Benchmark reference

EBITDA margin (target)30-40%
Staff expense %22-27%
Lab & supply %8-14%
Case starts / month30-60+
Treatment fee (avg)$5,500-$7,500
Orthodontist production$900K-$2M
Patient satisfaction4.5+/5.0
DSCR minimum1.25x

Practice Overview & Market Context

Orthodontics is among the highest-EBITDA-margin healthcare businesses available for acquisition. Cash-pay dominance, predictable multi-year treatment contract revenue, and high per-visit production create a financial profile that PE-backed orthodontic platforms (Dental Care Alliance, Ivy Orthodontics, Brident, SmilePop) prize heavily. Average EBITDA margins of 30-40% -- double the typical GP dental practice -- drive premium multiples of 6-9x for well-run operations.

The Invisalign revolution and direct-to-consumer orthodontics (SmileDirectClub, Byte) have disrupted the lower end of the market, but have paradoxically reinforced the premium for highly trained orthodontists. Patients increasingly seek out board-certified orthodontists for complex cases, and the aesthetic dentistry boom (adults now represent 25%+ of orthodontic patients) has expanded the addressable market. New case starts per month is the single most important metric -- it is the heartbeat of the practice.

Value accelerators

High case start volume -- 40+ new cases per month signals demand, marketing effectiveness, and GP referral network strength
Multiple locations -- a 2-3 location orthodontic group commands significantly higher multiples than a single office due to reduced key-person risk
Strong GP referral network -- documented referral relationships with 20+ GP dentists are difficult to replicate and highly valuable
Invisalign Elite / Diamond status -- top-tier Invisalign provider status signals volume, expertise, and differentiated marketing
Low lab fees -- in-house or digital workflows reduce lab costs and improve margin
Diverse age mix -- adult patients (25%+) signal premium treatment acceptance and higher average fees

Value discounts

Single-location, single-provider -- owner-doctor doing 100% of treatment with no associate is a key-person risk for any buyer
Concentated GP referral sources -- if 50%+ of new patients come from 1-2 referring dentists, losing those relationships impairs revenue
Medicaid / low-fee orthodontics -- practices serving primarily Medicaid orthodontic programs have lower per-case revenue and compress margins
Aging equipment -- CBCTs, 3D scanners (iTero), digital X-ray are table stakes for modern practices
Short lease -- under 5 years remaining; orthodontic practices need 10+ year lease certainty for both lenders and PE buyers
🦷

The treatment contract revenue model

Unlike most healthcare practices, orthodontic practices collect fees on a contract basis: patients sign a treatment agreement for the full fee upfront (or via financing), with collection occurring over the treatment period (12-30 months). This creates deferred revenue on the balance sheet -- the practice has collected cash (or contracted for it) for treatment not yet delivered. In a sale, the buyer assumes liability for completing those cases; the deferred revenue balance is typically excluded from EBITDA and handled via a working capital adjustment.